Filtros de búsqueda

Lista de obras de Romualdo Barroso-Sousa

A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer

artículo científico publicado en 2020

Abstract PS4-25: Comprehensive genomic analysis reveals molecular correlates of response to immune checkpoint inhibitors (ICI) in metastatic triple-negative breast cancer (mTNBC)

artículo científico publicado en 2021

Activity and safety of sunitinib in poor risk metastatic renal cell carcinoma patients.

artículo científico publicado en 2014

Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study

scientific article published on 24 April 2020

Biological therapies in breast cancer: common toxicities and management strategies

artículo científico

Cardiac safety of (neo)adjuvant trastuzumab in the community setting: a single-center experience

artículo científico publicado en 2014

Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy

artículo científico publicado en 2017

Clinical Development of the CDK4/6 Inhibitors Ribociclib and Abemaciclib in Breast Cancer

artículo científico publicado en 2016

Complete resolution of hypercortisolism with sorafenib in a patient with advanced medullary thyroid carcinoma and ectopic ACTH (adrenocorticotropic hormone) syndrome.

artículo científico publicado en 2014

Comprehensive cancer-gene panels can be used to estimate mutational load and predict clinical benefit to PD-1 blockade in clinical practice.

artículo científico publicado en 2015

De-escalating treatment in the adjuvant setting in HER2-positive breast cancer.

artículo científico publicado en 2018

Decreased levels of alpha-1-acid glycoprotein are related to the mortality of septic patients in the emergency department

scientific article published on January 2013

Definitive chemoradiotherapy for advanced cervical cancer: should it be different in the elderly?

artículo científico publicado en 2015

Differences between invasive lobular and invasive ductal carcinoma of the breast: results and therapeutic implications

artículo científico publicado en 2016

Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical Trial

artículo científico publicado en 2020

Endocrine dysfunction induced by immune checkpoint inhibitors: Practical recommendations for diagnosis and clinical management.

artículo científico publicado en 2018

Exploring the role of metformin in anticancer treatments: a systematic review.

artículo científico publicado en 2014

Genomic characterization of de novo metastatic breast cancer

scientific article published on 08 December 2020

High IL-1R8 expression in breast tumors promotes tumor growth and contributes to impaired antitumor immunity.

artículo científico publicado en 2017

Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials

scientific article published on 15 November 2019

Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis.

artículo científico publicado en 2017

Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2- locally advanced breast cancer

artículo científico publicado en 2015

Metronomic oral cyclophosphamide plus prednisone in docetaxel-pretreated patients with metastatic castration-resistant prostate cancer

scientific article published on 18 December 2014

Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer

artículo científico publicado en 2021

Neoadjuvant endocrine therapy in breast cancer: current role and future perspectives

artículo científico publicado en 2016

Neutrophil Extracellular Traps Induce Organ Damage during Experimental and Clinical Sepsis

artículo científico publicado en 2016

Optimal treatment of early stage HER2-positive breast cancer

artículo científico publicado en 2018

PD-1 inhibitors in endometrial cancer

artículo científico publicado en 2017

Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer

artículo científico publicado en 2020

Pre-treatment neutrophil-to-lymphocyte ratio affects survival in patients with advanced hepatocellular carcinoma treated with sorafenib

artículo científico publicado en 2014

Reply to Garcia J. et al

artículo científico publicado en 2017

Transformation of Old Concepts for a New Era of Cancer Immunotherapy: Cytokine Therapy and Cancer Vaccines as Combination Partners of PD1/PD-L1 Inhibitors

artículo científico publicado en 2018

Tumor mutational burden and PTEN alterations as molecular correlates of response to PD-1/L1 blockade in metastatic triple-negative breast cancer

scientific article published on 04 February 2020

Variation in the use of granulocyte-colony stimulating factor for dose dense paclitaxel: A single institution retrospective study

artículo científico publicado en 2016

Wnt/beta-catenin pathway: modulating anticancer immune response

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda